Agenda - Predictive Analytics World for Healthcare

For life science companies, healthcare providers, patients and consumers, AI offers great potential to streamline processes and achieve better treatment results. On the one hand, the findings from data generated in the real world setting could take personalized medicine to a new level by individually tailoring diagnosis and treatment in terms of effectiveness and safety to the patient. On the other hand, the linking of clinical study data and real world data with the enormous advances in biology and medicine is a prerequisite for more targeted research and more efficient development processes. In her talk Dr. Anna Bauer-Mehren describes the role of real world data, data science or data analysis in pharmaceutical research and the resulting new opportunities for personalized medicine. In particular, she addresses the importance of high quality data and Roche's efforts to make data FAIR.